FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/07/020429 [Registered on: 29/07/2019] Trial Registered Prospectively
Last Modified On: 13/03/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Single Arm Study 
Public Title of Study   To study the effect of injection Bupivacaine(0.25%) into abdominal cavity for postoperative pain relief following Laparoscopic cholecystectomy 
Scientific Title of Study   To study the effect of instillation of intraperitoneal Bupivacaine (0.25%) to achieve postoperative analgesia in patients undergoing Laparoscopic cholecystectomy  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Avinash Banjare 
Designation  PG Student 
Affiliation  Pt J N M Medical college, Raipur (C.G.) 
Address  Department of Anaesthesiology and Critical care Pt J N M Medical College, Raipur Chhattisgarh

Raipur
CHHATTISGARH
492001
India 
Phone  8120507490  
Fax    
Email  banjare.avinash@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pratibha Jain Shah 
Designation  Professor & HOD 
Affiliation  Pt J N M Medical College, Raipur, (C.G.) 
Address  Department of Anaesthesiology and Critical care Pt J N M Medical College, Raipur Chhattisgarh

Raipur
CHHATTISGARH
492001
India 
Phone    
Fax    
Email  prati_jain@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Avinash Banjare 
Designation  PG Student 
Affiliation  Pt J N M Medical College 
Address  Department of Anaesthesiology and Critical care Pt J N M Medical College, Raipur Chhattisgarh

Raipur
CHHATTISGARH
492001
India 
Phone  8120507490  
Fax    
Email  banjare.avinash@gmail.com  
 
Source of Monetary or Material Support  
Dr Avinash Banjare PG RESIDENT Department of anaesthesiology and crtical care Pt J N M Medical College and Dr BRAM Hospital, Raipur. (C. G.) 
 
Primary Sponsor  
Name  Department of anaesthesiology and crtical care 
Address  Department of Anaesthesiology and Critical care Pt J N M Medical College, Raipur Chhattisgarh 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Avinash Banjare  Pt J N M Medical College and Dr B R A M hospital, Raipur  Department of anaesthesiology and critical care Raipur, Chhattisgarh 492001
Raipur
CHHATTISGARH 
8120507490

banjare.avinash@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Pt JNM Medical College Raipur (C. G)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K801||Calculus of gallbladder with othercholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Instillation of intraperitoneal Bupivacaine (0.25%) 40ml in Patients undergoing laparoscopic cholecystectomy.  Bupivacaine (0.25%). Intraperitoneal Instillation in the sub diaphragmatic suprahepatic surface of liver and gall bladder fossa. Dose is 40ml of 0.5%. Frequency is single dose of bolus.  
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA grade I-II
Age 18 – 60 years
Weight 45-85Kg
A patient undergoing Laparoscopic Cholecystectomy under General Anaesthesia. 
 
ExclusionCriteria 
Details  Needing bile duct exploration, insertion of a T-drain.
Acute cholecystitis.
Surgery-related complication example, bile spillage or conversion to open cholecystectomy
Duration of surgery exceeded 2 hours.
Severe systemic disease.
Prolong Analgesics ingestion
Allergy to local anesthetics. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Proportion of patients having Visual Analog Score(VAS)3 at 3hours  Proportion of patients having Visual Analog Score(VAS)3 at 3hours 
 
Secondary Outcome  
Outcome  TimePoints 
Duration of analgesia
Haemodynamic Variables such as Heart Rate (HR), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)
24 hours analgesia requirement
Sideeffects such as Post Operative nausea, vomiting and respiratory depression 
every 2 hours 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/08/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Other (Terminated) 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   My Thesis is to study the effect of instillation of intraperitoneal Bupivacaine (0.25%) to achieve postoperative analgesia in 50 patients undergoing Laparoscopic Cholecystectomy.  Patients belonging to ASA grade I-II, aged 18year to 60years, weighing between 45-85 Kgs, undergoing Laparoscopic Cholecystectomy under General Anaesthesia are selected for the study.
After removal of gallbladder and haemostasis achieved, residual blood and fluid will be thoroughly suctioned. The surgeon will instill 40ml of 0.25% Bupivacaine in the subdiaphragmatic suprahepatic surface of liver and gall bladder. In the postoperative period, we observe the duration of analgesia using Visual Analog Score, hemodynamic variables, 24 hours analgesic requirement, and any side effects.
 
Close